2022
Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study
Jia J, Zhu Q, Deng L, Lan G, Johnson A, Chen H, Shen Z, Li J, Xing H, Ruan Y, Li J, Lu H, Vermund SH, Zhu J, Qian HZ. Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study. Infectious Diseases Of Poverty 2022, 11: 7. PMID: 34986877, PMCID: PMC8734096, DOI: 10.1186/s40249-021-00921-5.Peer-Reviewed Original ResearchConceptsHepatitis B virusHepatitis C virusAntiretroviral therapyHigh mortalityHCV coinfectionC virusNational Free Antiretroviral Treatment ProgramHBV co-infected patientsHBV/HCV coinfectionRetrospective cohort study analysisEffect of ARTCohort study analysisObservational cohort studyAntiretroviral treatment programOverall mortality rateProportional hazards modelTreatment attrition rateCause deathHCV-coHIV patientsBaseline infectionCohort studyHBV-HCVHepatitis BHepatitis treatment
2020
Public Health and Clinical Implications of Nutrition-Infection Interactions
Vermund S, Scott M, Humphries D. Public Health and Clinical Implications of Nutrition-Infection Interactions. Nutrition And Health 2020, 459-481. DOI: 10.1007/978-3-030-56913-6_16.Peer-Reviewed Original ResearchInfectious agentsNutritional statusClinical implicationsRole of obesityDefinitive risk factorsSeverity of malariaSuboptimal nutritional statusMajor infectious agentsHealth of personsClinical courseClinical managementRisk factorsClinical nutritionHigh mortalityInfectious diseasesCOVID-19ObesityPublic healthInfectionDiseaseSeverityNutritionHealthBacterial diseasesStatus
2013
Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
Liao L, Xing H, Su B, Wang Z, Ruan Y, Wang X, Liu Z, Lu Y, Yang S, Zhao Q, Vermund SH, Chen RY, Shao Y. Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China. AIDS 2013, 27: 1815-1824. PMID: 23803794, PMCID: PMC3694318, DOI: 10.1097/qad.0b013e3283611931.Peer-Reviewed Original ResearchConceptsCombination antiretroviral therapyHIV drug resistanceImmunologic failureHigh mortalityVirologic failureAntiretroviral therapyEmergence of HIVDRBaseline CD4 cell countDrug resistanceCD4 cell countCohort of patientsSecond-line drugsEnd of studyProportional hazards modelRural Chinese countiesHIVDR mutationsMedian timePatient adherenceKaplan-MeierChinese patientsRisk factorsHazards modelPatientsCell countMortality
2011
Barriers to antiretroviral therapy adherence in rural Mozambique
Groh K, Audet CM, Baptista A, Sidat M, Vergara A, Vermund SH, Moon TD. Barriers to antiretroviral therapy adherence in rural Mozambique. BMC Public Health 2011, 11: 650. PMID: 21846344, PMCID: PMC3171727, DOI: 10.1186/1471-2458-11-650.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnti-Retroviral AgentsAttitude of Health PersonnelAttitude to HealthCommunity Health ServicesCommunity Health WorkersCommunity-Based Participatory ResearchConfidentialityFemaleFocus GroupsHealth Services AccessibilityHIV InfectionsHumansMaleMedication AdherenceMozambiqueProfessional-Patient RelationsQualitative ResearchRural Health ServicesSocioeconomic FactorsConceptsHealth care workersCare workersAntiretroviral therapyPoor adherenceRural Zambézia ProvinceAntiretroviral therapy adherenceSuboptimal adherenceLack of confidentialityPatient adherencePoor treatmentTherapy adherencePatient preferencesMedications resultsChronic diseasesFocus groupsSide effectsZambézia ProvinceHospital staffHigh mortalityClinical sitesViral mutationsEffective interventionsAdherenceTraditional medicineMedications